Sign In
Buy SNY
$43.98
-0.680 (-1.52%)
At Close: Jul 20, 2026
Sanofi raises profit forecasts after strong second quarter
01:39am, Thursday, 29'th Jul 2021
Sanofi raised its 2021 outlook after its vaccines and star eczema treatment Dupixent helped it post better-than-expected second-quarter results on Thursday.
Sanofi's Pompe Disease Enzyme Replacement Therapy Gets EMA's CHMP Backing
02:49pm, Tuesday, 27'th Jul 2021
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Sanofi SA's (NASDAQ: SNY) avalglucosidase alfa for Pompe disease. The
7 Cheap Value Stocks to Buy for August 2021
02:23pm, Tuesday, 27'th Jul 2021
These cheap value stocks have the potential to provide shareholders with long-term growth that exceeds their current limiting valuations. The post 7 Cheap Value Stocks to Buy for August 2021 appeared
Sanofi-Regeneron's COPD Drug Fails In Mid-Stage Trial, But Shows Potential Benefit In Subgroup of Former Smokers
01:22pm, Thursday, 22'nd Jul 2021
Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc (NASDAQ: REGN) started their collaboration in chronic obstructive pulmonary disorder (COPD) to target all patients, and the data is pointin
15 European Dividend Aristocrats to Diversify Your Portfolio
01:47pm, Wednesday, 21'st Jul 2021
Plenty of investors focus in on dividends, and dividend aristocrats, but if those investors only look in the U.S. they could be missing out. The post 15 European Dividend Aristocrats to Diversify Your
EMA Starts Rolling Review Of Glaxo - Sanofi COVID-19 Vaccine
02:32pm, Tuesday, 20'th Jul 2021
EMA's human medicines committee has kicked off a rolling review of a COVID-19 vaccine from Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline plc (NASDAQ: GSK), which started a 35,000-patient Phase
Sanofi's Oral Treatment For Sleeping Sickness Gets FDA Approval
01:19pm, Monday, 19'th Jul 2021
The FDA has approved Sanofi SA's (NASDAQ: SNY) fexinidazole as the first all-oral treatment for both stages of the Trypanosoma brucei gambiense form of sleeping sickness in patients six years of ag
Is This Coronavirus Stock Undervalued?
06:30am, Wednesday, 14'th Jul 2021
This biotech giant might be down, but it isn't out just yet.
Sanofi announces Paris 2024 Premium partnership for the Olympic and Paralympic Games in Paris
01:30am, Tuesday, 13'th Jul 2021
Press release Source: Sanofi (EURONEXT: SAN) (NASDAQ: SNY)
IDNA: Genetics Now Have A Lot Of Influence On Healthcare
03:12am, Saturday, 10'th Jul 2021
IDNA: Genetics Now Have A Lot Of Influence On Healthcare
Sanofi (SNY) is a Top Dividend Stock Right Now: Should You Buy?
12:47pm, Thursday, 08'th Jul 2021
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Sanofi (SNY) have what it takes?
Is Sanofi (SNY) Stock Undervalued Right Now?
12:47pm, Thursday, 08'th Jul 2021
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
WHO Guidelines Put Spotlight on Arthritis Drugs Actemra & Kevzara
12:02pm, Thursday, 08'th Jul 2021
The latest guideline update by the WHO includes the use of arthritis drugs like Roche's (RHHBY) Actemra and Sanofi's (SNY) Kevzara for the treatment of severe COVID-19.
Sanofi, GSK Get Nod For Late-Stage COVID-19 Vaccine Trial In India
09:19am, Thursday, 08'th Jul 2021
Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline Plc (NYSE: GSK) have received approval from the Drug Controller General of India (DCGI) for a late-stage clinical trial of their protein-based COVID-19
WHO Recommends IL-6 Drugs From Sanofi, Roche For Critically-Ill COVID-19 Patients
11:47am, Wednesday, 07'th Jul 2021
The World Health Organization (WHO) has endorsed Interleukin-6 (IL-6) receptor antagonists combined with corticosteroids to treat severe COVID-19 cases. Patients severely or critically ill with COVI
